The single radial hemolysis (SRH) 
The single radial hemolysis (SRH) test In single radial hemolysis (SRH) tests, test sera are added to wells in an agarose gel containing antigen-sensitized erythrocytes. In the presence of complement, sera produce areas of hemolysis proportional to the concentration of specific antibody. As an alternative to the hemagglutination inhibition (HI) method for rubella antibody determination, SRH has the advantage that no pretreatment of sera for removal of nonspecific inhibitors and agglutinins is required. Moreover, in the SRH test only small volumes of sera are required (5 ,ul) , and the test is simple to perform, easy to read, and relatively inexpensive (6) .
The SRH test has gained wide acceptance in a number of countries as a screening test for rubella antibodies, although it is not widely used for this purpose in North America. The British Public Health Laboratory Service and other laboratories in Sweden and Australia have adopted the SRH test for immune status determination (9, 11, 20) . Mortimer et al. (13) suggested recently that the threshold for reporting immunity to rubella be lowered from 15 IU of antibody per ml. Individuals having some detectable antibody at levels below 15 IU fail to produce rubella-specific immunoglobulin M (IgM) antibody in response to vaccination with RA 27/3; however, individuals without detectable SRH antibody do (13) .
The question of what constitutes a diagnostically significant difference between the SRH antibody levels in acute-and convalescentphase sera has been addressed by few authors. Mortimer et al. (13) Forger and Gilfillan (6) used a fourfold HI equivalent change in SRH titer for diagnosis of recent rubella infection.
Antibody of the IgM class is not detected by SRH (9, 16, 20) . Champsaur et al. (4) reported that SRH does not detect antibody earlier than 6 days after the onset of rash.
In this study data are presented to show that selecting an SRH diagnostic diameter difference equivalent to a fourfold change in international units yields a diagnostic index which is both sensitive and highly specific due to the small degree of variability that occurs in the SRH test. The threshold SRH antibody level indicative of immunity is discussed. Other antibody test methods. The HI method of Halonen et al. (8) with kaolin serum treatment at pH 9.0 and chick indicator cells was used, modified only in that cold incubation was at 4°C. Rubazyme enzymelinked immunosorbent assay (ELISA) (Abbott Laboratories, North Chicago, Ill), Ortho Rubella ELISA (Ortho Diagnostics, Don Mills, Ontario), and Gamma Coat radioimmunoassay (RIA) (Clinical Assays Division of Travenol Laboratories Inc., Cambridge, Mass.) tests were conducted on those sera which gave discrepant results by HI and SRH. In sera fractionated by sucrose density gradient (SDG) centrifugation (14) , the presence of rubella-specific antibodies was detected by HI testing of fractions. An 18-h incubation of antigen and antibody was used to enhance sensitivity. Immunoglobins in the fractions were identified by class-specific radial immunodiffusion plates for low levels of human immunoglobins (Hyland Diagnostics, Deerfield, Ill.). The presence of rubella-specific antibodies in the IgM fractions was confirmed by a fourfold reduction of HI titer by 2-mercaptoethanol treatment (15) .
Sera. Three hundred and forty-three single serum specimens used in this study were received for rubella immune status determination. Serum samples taken from patients during each trimester of pregnancy and immediately postpartum were provided through the cooperation of Juan Embil of the Infectious Disease Research Laboratory, Izaak Walton Killam Hospital for Children, Halifax, Nova Scotia. Acute-and convalescent-phase serum pairs were submitted for reference testing or provided by Micheline Fauvel, Institut Armand-Frappier, Laval, Quebec. Rheumatoid factor (RF)-positive sera, as determined by RA Test (Hyland Diagnostic), were provided by J. Dunne, Rheumatology Department, Ottawa General Hospital, Ottawa, Ontario. Sera containing high levels of heterophile antibody were supplied by J. H. Joncas, Microbiology Department, St. Justine Hospital, Montreal, Quebec.
RESULTS
Serum inactivation. The effect of serum inactivation on hemolysis patterns was investigated. Most non-inactivated sera produced faint hemolysis patterns. Similarly, mnost non-inactivated sera had halos of incomplete lysis surrounded by an area of greater lysis. Zones elicited by sera inactivated at 56°C for 15 min were much clearer and improved further with increased inactivation time. A 1-h period of inactivation at 56°C did not give any improvement in results over a 45-min period of inactivation. Inactivation at 60°C for 20 min produced the clearest zones with the fewest halos, and this inactivation period was adopted as standard procedure throughout the study.
NSH. The observed incidence of nonspecific hemolysis (NSH) in control plates was 2.3%, with NSH exceeding a 5-mm diameter in 0.5% of the sera tested. The minimum observed difference between NSH and rubella-specific diameters was 3.4 mm. Some NSH may be attributable to heterophile antibody. In 10 sera containing high levels of heterophile antibody, 4 produced NSH zones >3.5 mm. These zones were abolished by sheep erythrocyte absorption.
Halo formation. The association of RF-containing sera and anticomplementary (AC) sera with halo formation was examined. For VOL. 17, 1983 on October 12, 2017 by guest http://jcm.asm.org/ No specific hemolysis.
DISCUSSION
Kurtz et al. (11) found that serum inactivation at 60°C for 20 min reduced the frequency of NSH in SRH to below that observed with the usual 56°C for 30 min regime. In this study, 60°C inactivation optimally reduced the incidence of halo formation and produced the clearest zones of lysis. Gee et al. (7) reported that RF may interfere with SRH. In this study the incidence of halo formation was no greater with RFpositive than with RF-negative sera. Similarly, AC sera did not significantly increase halo formation.
NSH did not interfere with the interpretation of any serum titer. Should NSH interfere with test reading and erythrocyte adsorption fail to remove NSH, an alternative test method should be used.
The linear relationship between HI titer and SRH diameter for sera with HI titers >1:8 ( Fig.  1) confirmed that found by other authors (7, 9, 11, 17) . With (13) .
False-positive antibody detection by conventional tests ranges from 3 to 14.3% (1, 2, 12, 19, 21) . False positivity in assays by commercial kits may reach 27% (3). In light of these unacceptable levels, the highly specific SRH may be an attractive alternative for immune status determination, despite the requirement for biweekly plate preparation.
That the SRH test can be made extremely sensitive was shown by using the modification of Champsaur and Slim (5), which allowed detection of 1.25 IU with a larger inoculum and a longer diffusion period. Even without this modification, the SRH test detected 5 IU of antibody, well below the 15 IU detectable by the HI test.
The distribution of SRH diameters (Fig. 2) showed that very few sera had antibody levels in the critical region within which a decision about immune status is made (5 to 15 IU). With the HI test, there were about as many sera with titers of 1:8 as with titers <1:8; many more sera fell within the borderline immune-susceptible region.
Rubella SRH does not detect IgM, nor does it reliably detect very early IgG (<5 days postrash), although with some sera early IgG may produce faint lysis (Table 2 ). Hoppe and Drescher (10) indicated that early antibody to rubella is of a different quality than later antibody. The early IgG antibody may lack the ability to activate or bind complement as effectively as later antibody does. The insensitivity of SRH to IgM and early IgG may be used to advantage in that serum pairs taken too late to show a fourfold rise in HI titer may still demonstrate a diagnostic increase by SRH; indeed, five pairs of sera showed such an increase by SRH. Although specific IgM was present in each case, no evidence of recent infection was seen based on HI titers alone. This emphasizes the utility of alternative methods which detect later-rising antibody when exposure to rubella is suspected.
A 2.5-mm difference in SRH diameters between serum pairs was chosen as being of diagnostic significance. The rationale for using the 2.5-mm difference was threefold. (i) By convention, a fourfold rise in serological tests is diagnostically significant, and a fourfold change in international units measured by SRH corresponds to -2.5 mm. From the slopes of standard curves prepared for each SRH test, a fourfold change in international units corresponds to a diameter change of 2.5 mm. (ii) This difference in diameters is less than the minimum observed difference of 2.9 mm between 59 acute-and convalescent-phase serum pairs with demonstrable fourfold changes in HI titer. For the most part, the diameter differences were dramatic (mean difference, 9.3 mm). (iii) A 2.5-mm change (fourfold change in international units) far exceeds the combined within-test and individual variability (largest SD, 0.69 mm) seen in the sequential samples from 95 pregnant women. The within-test variability of the SRH test for replicates of the same serum was small (mean SD, 0.33 mm). However, this does not take into account possible inherent fluctuations in antibody level in the same individual over time. The variation in antibody level between first trimester and term in the sera of 95 pregnant women was also small (mean SD, 0.39 mm). From the foregoing discussion, an SRH diagnostic diameter difference based on a fourfold change in antibody level measured in international units appears to be a reasonable, although conservative, choice. With further clinical experience and study, less than fourfold changes in antibody level may be found to be an acceptable diagnostic criterion for tests with high levels of precision.
In this study, the 18% decrease in rubella SRH titer between first and third trimester in all cases represented a less than fourfold change in HI titer. This decrease in specific antibody was consistent with the observed overall decrease in total IgG of 18.6%. In the population examined by Skaug et al. (18) , a mean decrease in rubella SRH titer of 30% was reported between the 13th and 35th week of gestation. The decrease in antibody levels may be attributable to an increased plasma volume or hemodilution during pregnancy (22) .
In summary, the SRH test provides a specificity and sensitivity which make it suitable for diagnosis of recent infection as well as for immune status determination. Interlaboratory variability in the reporting of immune status or diagnostic changes may be reduced by use of an international standard serum (or secondary national reference preparations) with SRH titers expressed in international units.
